DexCom, Inc. (DXCM)
Pre-market:
| Previous close | 137.87 |
| Open | 138.87 |
| Bid | 137.97 x 100 |
| Ask | 138.10 x 100 |
| Day's range | 134.45 - 139.24 |
| 52-week range | 74.75 - 142.00 |
| Volume | |
| Avg. volume | 3,087,224 |
| Market cap | 54.656B |
| Beta (5Y monthly) | N/A |
| PE ratio (TTM) | 106.16 |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- Business Wire
Dexcom Reports First Quarter 2024 Financial Results
SAN DIEGO, April 25, 2024--DexCom, Inc. (Nasdaq: DXCM) today reported its financial results as of and for the quarter ended March 31, 2024.
- Business Wire
Dexcom Publishes Annual Sustainability Report
SAN DIEGO, April 03, 2024--DexCom, Inc. (NASDAQ:DXCM), the leader in real-time continuous glucose monitoring (CGM) for people with diabetes, today released its annual Sustainability Report. This report provides updates on key corporate sustainability initiatives that are aligned with Dexcom’s core values and business strategy.
- Business Wire
Dexcom Schedules First Quarter 2024 Earnings Release and Conference Call for April 25, 2024 at 4:30 p.m. Eastern Time
SAN DIEGO, April 02, 2024--DexCom, Inc. (NASDAQ:DXCM) today announced that it plans to release its first quarter 2024 financial results after market close on Thursday, April 25, 2024. Management will hold a conference call to review the company's first quarter 2024 performance starting at 4:30 p.m. (Eastern Time) on the same day. The conference call will be concurrently webcast. The link to the webcast will be available on the Dexcom investor relations website at investors.dexcom.com and will be
